Magnolia extract containing compositions
US11660259B2 · kind B2 · utility
0Cited by
50References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 20, 2021 |
| Grant date | May 30, 2023 |
| Priority date | — |
| Expiry date | Jun 27, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2800/782
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed is a powder composition consisting essentially of Magnolia officinalis bark extract comprising magnolol and honokiol, tocopherol or tocopherol acetate, lecithin, at least one gum, and optionally water, wherein the composition is in powdered form.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.